-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BMJqQI0ZjnkUJRBU6fmf1iUHe4TyZ2zmVDresbM2LIBrLELRrtuoLfm64Zt0AFuX Xe7rEEiw9ADzLNC9dJk44w== 0000950120-04-000694.txt : 20041025 0000950120-04-000694.hdr.sgml : 20041025 20041025170751 ACCESSION NUMBER: 0000950120-04-000694 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20041025 DATE AS OF CHANGE: 20041025 GROUP MEMBERS: VERUS INTERNATIONAL GROUP LIMITED GROUP MEMBERS: VERUS INVESTMENT HOLDINGS, INC. FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: KHAN AJMAL CENTRAL INDEX KEY: 0001092446 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: LAURISTON HOUSE SUITE 101 CITY: ST MICHAEL BARBADOS STATE: C8 MAIL ADDRESS: STREET 1: LAURISTON HOUSE SUITE 101 CITY: ST MICHAEL BARBADOS STATE: C8 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DIOMED HOLDINGS INC CENTRAL INDEX KEY: 0001074874 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 841480636 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78121 FILM NUMBER: 041094628 BUSINESS ADDRESS: STREET 1: 1 DUNDEE PARK CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 978-475-7771 FORMER COMPANY: FORMER CONFORMED NAME: NATEXCO CORP DATE OF NAME CHANGE: 20001128 SC 13D/A 1 d624985.txt SCHEDULE 13D/A, AMENDMENT #7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7)* DIOMED HOLDINGS, INC. --------------------- (Name of Issuer) Common Stock, par value $0.001 per share ---------------------------------------- (Title of Class of Securities) 25454R207 --------- (CUSIP Number) Mr. Ajmal Khan c/o Verus International Group Limited 20 West 55th Street New York, New York 10019 ------------------------ (Name, Address, and Telephone Number of Person Authorized to Receive Notices and Communications) June 10, 2003 ------------- (Date of Event which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. /_/ Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - -------------------------------------------------------------------------------- CUSIP No. 25454R207 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. Ajmal Khan IDENTIFICATION NO. OF ABOVE PERSON - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS N/A - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Canada and United Kingdom - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER 1,466,491* SHARES ---------------------------------------------------------------- BENEFICIALLY 8 SHARES VOTING POWER OWNED BY ---------------------------------------------------------------- THE 9 SOLE DISPOSITIVE POWER 1,466,491* REPORTING ---------------------------------------------------------------- PERSON WITH 10 SHARED DISPOSITIVE POWER - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY 1,466,491* THE REPORTING PERSON - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW |_| (11) EXCLUDES CERTAIN SHARES - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.9% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN - -------------------------------------------------------------------------------- *Through his position as the majority owner of Verus International Group Limited and Verus Investment Holdings, Inc., Mr. Khan has the power to dispose of or direct the disposition of the shares of Common Stock. As a result, Mr. Khan may, under the rules of the Securities and Exchange Commission, be deemed to be the 2 beneficial owner of the shares of Common Stock. Mr. Khan disclaims beneficial ownership of the shares of Common Stock reported as beneficially owned by him, except to the extent of his pecuniary interest therein. 3 - -------------------------------------------------------------------------------- CUSIP No. 25454R207 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. Verus International IDENTIFICATION NO. OF ABOVE PERSON Group Limited - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS N/A - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER 125,900 SHARES ---------------------------------------------------------------- BENEFICIALLY 8 SHARES VOTING POWER OWNED BY ---------------------------------------------------------------- THE 9 SOLE DISPOSITIVE POWER 125,900 REPORTING ---------------------------------------------------------------- PERSON WITH 10 SHARED DISPOSITIVE POWER - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY 125,900 THE REPORTING PERSON - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW |_| (11) EXCLUDES CERTAIN SHARES - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.4% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON CO - -------------------------------------------------------------------------------- 4 - -------------------------------------------------------------------------------- CUSIP No. 25454R207 - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSONS I.R.S. Verus Investment IDENTIFICATION NO. OF ABOVE PERSON Holdings, Inc. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |X| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS N/A - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) |_| - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION British Virgin Islands - -------------------------------------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER 1,340,591 SHARES ---------------------------------------------------------------- BENEFICIALLY 8 SHARES VOTING POWER OWNED BY ---------------------------------------------------------------- THE 9 SOLE DISPOSITIVE POWER 1,340,591 REPORTING ---------------------------------------------------------------- PERSON WITH 10 SHARED DISPOSITIVE POWER - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY 1,340,591 THE REPORTING PERSON - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW |_| (11) EXCLUDES CERTAIN SHARES - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 4.5% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON CO - -------------------------------------------------------------------------------- 5 ITEM 1. SECURITY AND ISSUER. This Amendment No. 7 to the Schedule 13D, dated February 14, 2002, of Diomed Holdings, Inc., a Delaware corporation (the "Issuer"), is filed to reflect the information required pursuant to Rule 13d-2 of the Securities and Exchange Act of 1934, as amended (the "Act"), relating to common shares, $0.001 par value per share (the "Common Stock") of the Issuer. The Issuer's principal executive office is 1 Dundee Park, Andover, MA 01810. ITEM 2. IDENTITY AND BACKGROUND. (I) AJMAL KHAN (a) This statement is being filed on behalf of Ajmal Khan, an individual and majority owner of Verus International Group Limited and Verus Investment Holdings, Inc. (b) The business address of Mr. Khan is c/o Verus International Group Limited, 20 West 55th Street, New York, New York 10019. (c) Mr. Khan's principal occupation is private investor. (d)-(e) During the last five years Mr. Khan has not (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction where as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws. (f) Mr. Khan holds Canadian and United Kingdom citizenships. (II) VERUS INTERNATIONAL GROUP LIMITED This statement is being filed on behalf of Verus International Group Limited ("Verus International"), a British Virgin Islands corporation. Verus International is engaged in investment holdings. The address of Verus International's principal office is 20 West 55th Street, New York, New York 10019. (d)-(e) During the last five years no executive officer, director, or control person of Verus International has (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction where as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws. (III) VERUS INVESTMENT HOLDINGS INC. This statement is being filed on behalf of Verus Investment Holdings, Inc. ("Verus Investment"), a British Virgin Islands corporation. Verus Investment is engaged in investment holdings. The address of Verus Investment's principal office is 20 West 55th Street, New York, New York 10019. 6 (d)-(e) During the last five years no executive officer, director, or control person of Verus Investment has (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction where as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to federal or state securities laws or finding any violation with respect to such laws. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION Not applicable. ITEM 4. PURPOSE OF TRANSACTION (I) AJMAL KHAN On June 10, 2003, Mr. Khan sold 302,100 shares of Common Stock that he beneficially owns as the majority owner of Verus Investment through open market sales. (II) VERUS INTERNATIONAL GROUP LIMITED Not applicable. (III) VERUS INVESTMENT HOLDINGS, INC. On June 10, 2003, Verus Investment sold 302,100 shares of Common Stock that it beneficially owns through open market sales. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (I) AJMAL KHAN (a) As of the date of this report, Mr. Khan, through his majority ownership of Verus International and Verus Investment, beneficially owns an aggregate of 1,466,491 shares of Common Stock, which represents 4.9% of the Issuer's Common Stock. (b) As of the date of this report, Mr, Khan has the sole power to vote or direct the voting of, or dispose or direct the disposition of 1,466,491 shares of the Issuer's Common Stock. (c) Mr. Khan has not effected any transactions other than that described herein in the class of securities described since the most recent filing on Schedule 13D. (d) Not applicable. (e) Mr. Khan ceased to be a beneficial owner of more than 5% of the class of securities described herein on June 10, 2003. (II) VERUS INTERNATIONAL GROUP LIMITED (a) As of the date of this report, Verus International, beneficially owns an aggregate of 125,900 shares of Common Stock, which represents 0.4% of the Issuer's Common Stock. 7 (b) As of the date of this report, Verus International has the sole power to vote or direct the voting of, or dispose or direct the disposition of 125,900 shares of the Issuer's Common Stock. (c) Verus International has not effected any transaction other in the class of securities described since the most recent filing on Schedule 13D. (d) Not applicable. (e) Verus International ceased to be a beneficial owner of more than 5% of the class of securities described herein on May 27, 2003. (III) VERUS INVESTMENT HOLDINGS, INC. (a) As of the date of this report, Verus Investment, beneficially owns an aggregate of 1,340,591 shares of Common Stock, which represents 4.5% of the Issuer's Common Stock. (b) As of the date of this report, Verus Investment has the sole power to vote or direct the voting of, or dispose or direct the disposition of 1,340,591 shares of the Issuer's Common Stock. (c) Verus Investment has not effected any transactions other than that described herein in the class of securities described since the most recent filing on Schedule 13D. (d) Not applicable. (e) Verus Investment ceased to be a beneficial owner of more than 5% of the class securities described herein on June 10, 2003. ITEM 6. CONTRACTS, AGREEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER Not applicable. 8 S I G N A T U R E After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. Date: October 25, 2004 VERUS INVESTMENT HOLDINGS, INC. By: /s/ Ajmal Khan --------------------------------- Name: Ajmal Khan Title: Authorized Representative VERUS INTERNATIONAL GROUP LIMITED By: /s/ Ajmal Khan --------------------------------- Name: Ajmal Khan Title: Authorized Representative /s/ Ajmal Khan ------------------------------------- Ajmal Khan 9 EXHIBIT A JOINT FILING AGREEMENT PURSUANT TO RULE 13D-1(K)(1) In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D Amendment No. 7 (including any additional amendments thereto) with respect to the Common Stock of Diomed Holdings, Inc., and that this Agreement be included as an Exhibit to such joint filing. IN WITNESS WHEREOF, the undersigned hereby execute this Agreement this 25th day of October, 2004. VERUS INVESTMENT HOLDINGS, INC. By: /s/ Ajmal Khan --------------------------------- Name: Ajmal Khan Title: Authorized Representative VERUS INTERNATIONAL GROUP LIMITED By: /s/ Ajmal Khan --------------------------------- Name: Ajmal Khan Title: Authorized Representative /s/ Ajmal Khan ------------------------------------- Ajmal Khan i -----END PRIVACY-ENHANCED MESSAGE-----